Cyclacel Pharma (CYCC) Tops Q3 EPS by 18c

Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.47), $0.18 better than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Macy's (M) Stock: Street Underestimates Earnings Pressure From Share Loss, Says Analyst
• Linde (LIN) PT Lowered to $563 at Bernstein SocGen Group